These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11952539)

  • 1. Quantitative in situ evaluation of telomeres in fluorescence in situ hybridization-processed sections of cutaneous melanocytic lesions and correlation with telomerase activity.
    Miracco C; Margherita De Santi M; Schürfeld K; Santopietro R; Lalinga AV; Fimiani M; Biagioli M; Brogi M; De Felice C; Luzi P; Andreassi L
    Br J Dermatol; 2002 Mar; 146(3):399-408. PubMed ID: 11952539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
    Glaessl A; Bosserhoff AK; Buettner R; Hohenleutner U; Landthaler M; Stolz W
    Arch Dermatol Res; 1999; 291(2-3):81-7. PubMed ID: 10195394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous regression of cutaneous melanoma in sinclair swine is associated with defective telomerase activity and extensive telomere erosion.
    Pathak S; Multani AS; McConkey DJ; Imam AS; Amoss MS
    Int J Oncol; 2000 Dec; 17(6):1219-24. PubMed ID: 11078808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human telomerase RNA component expression in Spitz nevi, common melanocytic nevi, and malignant melanomas.
    Guttman-Yassky E; Bergman R; Manov L; Sprecher E; Shaefer Y; Kerner H
    J Cutan Pathol; 2002 Jul; 29(6):341-6. PubMed ID: 12135464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIalpha protein expression.
    Miracco C; De Santi MM; Luzi P; Lalinga AV; Laurini L; De Nisi MC; Angeloni G; Brogi M; Cardone C; Carducci A; Arcuri F; Tosi P; Rubino G; Pirtoli L
    Int J Oncol; 2003 Dec; 23(6):1529-35. PubMed ID: 14612923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
    Fullen DR; Zhu W; Thomas D; Su LD
    J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear pseudoinclusions in melanocytic naevi and melanomas.
    Rose DS
    J Clin Pathol; 1995 Jul; 48(7):676-7. PubMed ID: 7560180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.
    Ramirez RD; D'Atri S; Pagani E; Faraggiana T; Lacal PM; Taylor RS; Shay JW
    Neoplasia; 1999 Apr; 1(1):42-9. PubMed ID: 10935469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.
    Schmid P; Itin P; Rufli T
    Carcinogenesis; 1995 Jul; 16(7):1499-503. PubMed ID: 7614683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of mRNA of Telomerase Protein in Benign Naevi and Melanomas Using RNAscope.
    Baltzarsen PB; Georgsen JB; Nielsen PS; Steiniche T; Stougaard M
    Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):36-41. PubMed ID: 30095463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases.
    Mourmouras V; Fimiani M; Rubegni P; Epistolato MC; Malagnino V; Cardone C; Cosci E; Nisi MC; Miracco C
    Br J Dermatol; 2007 Sep; 157(3):531-9. PubMed ID: 17596146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting.
    Gonzalez AP; Kumar D; Sánchez RL
    Am J Dermatopathol; 1994 Aug; 16(4):372-6. PubMed ID: 7526724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of telomerase activity in cutaneous melanocytic proliferations.
    Miracco C; Pacenti L; Santopietro R; Laurini L; Biagioli M; Luzi P
    Hum Pathol; 2000 Sep; 31(9):1018-21. PubMed ID: 11014565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
    Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
    Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens.
    Abásolo A; Vargas MT; Ríos-Martín JJ; Trigo I; Arjona A; González-Cámpora R
    Clin Exp Dermatol; 2012 Dec; 37(8):838-43. PubMed ID: 22731835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moesin and CD44 expression in cutaneous melanocytic tumours.
    Ichikawa T; Masumoto J; Kaneko M; Saida T; Sagara J; Taniguchi S
    Br J Dermatol; 1998 May; 138(5):763-8. PubMed ID: 9666819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions.
    Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
    Melanoma Res; 2012 Feb; 22(1):70-6. PubMed ID: 22228276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of the value of Ag NOR staining in the identification of dysplastic and other borderline melanocytic naevi.
    MacKie RM; White SI; Seywright MM; Young H
    Br J Dermatol; 1989 Apr; 120(4):511-6. PubMed ID: 2471546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.